News
Jatenzo, an Oral Testosterone Replacement Therapy, Now Available
Jatenzo® (testosterone undecanoate; Clarus Therapeutics), an oral testosterone replacement therapy, is now available for the treatment of hypogonadism.
Your search for replac returned 48 results
News
SSRI Use Tied to Improved Joint Replacement Sx Outcomes
SSRIs users had significantly lower risk of revisions and aseptic revisions compared to those who were not administered an SSRI.
News
ACA Replacement Plan Revealed
Among the biggest changes in the proposed legislation is the elimination of current income-based subsidies for purchasing insurance, which would be substituted with age-based tax credits.
Slideshow
Clinical Challenge: Hair and Nail Changes
A 38-year-old African man is referred for evaluation of localized areas of hair loss and accompanying nail changes.
Drugs in the Pipeline
Intravenous Choline Chloride Fast-Tracked for Intestinal Failure-Associated Liver Disease
The FDA has granted Fast Track designation to intravenous choline chloride (Protara Therapeutics), an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure-associated liver disease.
MPR Weekly Dose Podcast, News
MPR Weekly Dose Podcast Episode 21
This week on the Pod we cover an insulin pump recall; Pharmacies running out of supplies in light of Covid-19 fears; Investigational Alzheimer disease treatments not meeting trial end points; A new cardiac ultrasound device; and a new oral testosterone replacement therapy.
News
New Pancreaze Formulation Approved With Extended Shelf Life
The Food and Drug Administration has approved a new formulation of Pancreaze (pancrelipase; Vivus) Delayed Release Capsules which would allow for an extended shelf life of 36 months.
Safety Alerts and Recalls
Class I Recall Issued for Transcatheter Heart Valve Delivery System
Edwards Lifesciences is recalling the SAPIEN 3 Ultra delivery system; the system is part of the Edwards SAPIEN 3 Transcatheter Heart Valve System. The Food and Drug Administration has identified this as a Class I recall, meaning use of the device could cause serious injuries or death. The SAPIEN 3 Ultra delivery system was distributed…
Drugs in the Pipeline
FDA Designates Pegzilarginase Breakthrough Therapy for Arginase 1 Deficiency
ARG1-D is a rare disease that presents with persistent hyperargininemia, and severe progressive neurological abnormalities.
News
OTC Urethral Support Device Now Available to Treat Stress Urinary Incontinence
An over-the-counter device to treat stress urinary incontinence (SUI) in women has been made available by Rinovum Women’s Health.
